Maxim Group initiated coverage on Stealth BioTherapeutics with a new price target

7/1/21 8:34:40 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Maxim Group initiated coverage of Stealth BioTherapeutics with a rating of Buy and set a new price target of $3.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MITO

Date	Price Target	Rating	Analyst
7/1/2021	$3.00	Buy	Maxim Group